Paracetamol was originally used therapeutically in the latter nineteenth century but did not receive much attention until after the 1940s when it was found to be a metabolite of phenacetin (Smith, 1958). It was given the approved name "Paracetamol " by the British Pharmacopoeia Commission in February, 1957, and was introduced into the 1963 edition of the British Pharmacopoeia. It has been considered as a possible substitute for phenacetin (e.g., Comely & Ritter, 1956) following reports of interstitial nephritis allegedly due to phenacetin (e.g., Editorial, 1965). We decided to study the toxicity of paracetamol following previous work in this laboratory on the acute oral toxicity of phenacetin (Boyd, 1959 and1960). The most interesting finding was that when death was delayed there was an associated necrosis of the liver.The initial objective was to compare the acute toxicity of paracetamol with that of phenacetin. Therefore the project was designed so that toxicity would be determined at the range of the LD50 given to albino rats by intragastric cannula. The oral LD50 of paracetamol has been reported somewhat lower than that of phenacetin in mice and higher in rats (Smith, 1958). In rats it has been found of the order of 3.0 to 4.5 g/kg (Renault, Rohrbach & Dugniolle, 1956;Smith, 1958). METHODSThe experiments were performed upon young male CBL-Wistar albino rats of 100 to 200 g body weight fed Purina laboratory chow and water ad libitum. Sixteen hours before paracetamol administration each rat was placed in a metabolism cage, 1 rat per cage, and deprived of food but not water. Paracetamol (Eastman) was then administered by intragastric cannula as a freshly prepared suspension in distilled water. The suspension was stabilized by the addition of gum tragacanth powder to 0.2% (w/v) and the volume administered was maintained constant at 20.0 ml./kg since Ferguson (1962) has shown that drug toxicity can increase with increasing volume per kg of distilled water vehicle. Each of the following doses, expressed as g/kg, was given to 15 to 20 rats: 0.0, 2.0, 2.5, 3.0, 3.5, 4.0, 4.5, 6.0, and 7.0. Following drug administration the rat was returned to its metabolism cage which contained a weighed amount of food (50 g) and a measured amount of water (100 ml.).Clinical measurements were made upon each rat at daily, or shorter if indicated, intervals for 5 days. Survivors were then returned to the animal boarding quarters and observed for one month.Clinical measurements included body weight in g, food consumption in g rat feed/kg body weight per 24 hr, water consumption in ml./kg per 24 hr, colonic temperature in°C, urinary volume in ml./kg per 24 hr, urinary glucose output in mg/kg per 24 hr, urinary pH of 24 hour sample, urinary protein output in mg/kg per 24 hr, and other clinical signs quantitated at 1 + to 4+. Colonic temperature was recorded by a Thermistemp Telethermometer (Yellow Springs Instrument
Pregnancy in women has been shown by Boyd (1) to be accompanied by a lipemia involving certain definite changes in the lipid concentration of the red blood cells and blood plasma. Correlating this with earlier work the conclusion was reached that the increase in the concentration of blood lipids commences about midway in the nine months of gestation. Fat metabolism in the fetus also becomes active about the mid-point of pregnancy as indicated by increasing amounts of lipids being laid down in the growing offspring (2). The time relationship of these two processes suggests that they may be related.To prove or disprove this possible relation was the purpose of the present investigation. As a working hypothesis it was suggested that as the lipid concentration in the maternal blood stream increases, the placenta passes more of these substances on to umbilical blood from whence they are absorbed in increasing amounts by the fetus. This theory requires proof (a) that lipids are absorbed from umbilical blood by the fetus, and (b) that lipids are added to umbilical blood by the placenta. The placenta of the rabbit and rat has been shown in recent years to be "permeable" to lipids by Bickenbach and Rupp (14), Sinclair (15) and Chaikoff and Robinson (16). By analogy the human placenta has been assumed to be "permeable" also. Direct proof of the " permeability " of the human placenta to lipids is lacking and it should be recalled that the structure of the human placenta differs from that of the rat and the rabbit. In fact Slemons and Stander (3) and many others as reviewed by Needham (2), Mayer (4), Schlossmann (5), etc., believe that the human placenta does not permit the passage of fats to the fetal circulation because they found that the lipid concentration of blood on the maternal side of the placenta was always higher than
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.